Trial · NCT03204786
Outcomes48
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
21 to 40 of 48
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| SECONDARY | Change From Baseline on Urine Clinical Labs (Osmolality) During Treatment. | baseline to 4-week, 8-week, and 12-week | Participants with available data at the respective time point | mOsm/kg | MEAN |
| SECONDARY | Change From Baseline on Vital Signs (Systolic Blood Pressure) During Treatment. | Up to 12 weeks | Participants with available data at the respective time point | mmHg | MEAN |
| SECONDARY | Change From Baseline on Vital Signs (Diastolic Blood Pressure) During Treatment. | Up to 12 weeks | Participants with available data at the respective time point | mmHg | MEAN |
| SECONDARY | Change From Baseline on Vital Signs (Pulse) During Treatment. | Up to 12 weeks | Participants with available data at the respective time point | beats per minute (BPM) | MEAN |
| SECONDARY | Change From Baseline on Height During Treatment. | baseline to 4-week, 8-week, and 12-week | Participants with available data at the respective time point | cm | MEAN |
| SECONDARY | Change From Baseline on Weight During Treatment. | baseline to 4-week, 8-week, and 12-week | Participants with available data at the respective time point | kg | MEAN |
| SECONDARY | Change From Baseline on the Dosage Record Treatment Emergent Symptom Scale (DOTES) During Treatment. | Up to 12 weeks | Participants with available data at the respective time point | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Change From Baseline in Overt Aggression Scale (OAS) During Treatment. | 2-week, 4-week; 6-week, 8-week | |||
| SECONDARY | Baseline Vasopressin Concentration Predicting Primary and Secondary Behavioral Outcome Measures. | 4-week; 8-week | |||
| SECONDARY | Adverse Event Severity | Up to 12 weeks | Participants | COUNT_OF_PARTICIPANTS | |
| OTHER_PRE_SPECIFIED | Change From Baseline in Vineland Adaptive Behavior Scales, Third Edition (VABS-3) - Social Skills and Relationships Domain During Treatment. | 4-week; 8-week | |||
| OTHER_PRE_SPECIFIED | Change From Baseline in Parent Rated Pediatric Quality of Life (PedsQL) Inventory Scores During Treatment. | 4-week; 8-week | |||
| OTHER_PRE_SPECIFIED | Change From Baseline on Eye Gaze Assessment (Eye Tracking) During Treatment. | 4-week; 8-week | |||
| OTHER_PRE_SPECIFIED | Change From Baseline on the Developmental Neuropsychological Assessment, Second Edition (NEPSY-II) Theory of Mind Test During Treatment. | 4-week; 8-week | |||
| OTHER_PRE_SPECIFIED | Change From Baseline the Diagnostic Analysis of Nonverbal Accuracy, Second Edition (DANVA-2) Child Voices Prosody Test During Treatment. | 4-week; 8-week | |||
| OTHER_PRE_SPECIFIED | Change From Baseline in Parent Rated Stanford Social Motivation Scale (Also Known as the Stanford Social Dimensional Scale) Total Scores During Treatment. | 4-week; 8-week | |||
| OTHER_PRE_SPECIFIED | Change From Baseline in Parent Rated Anxiety Scale - Autism Spectrum Disorder (PRAS-ASD) Score During Treatment. | 4-week; 8-week | |||
| OTHER_PRE_SPECIFIED | Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Social Avoidance Factor Score During Treatment. | 4-week; 8-week | |||
| OTHER_PRE_SPECIFIED | Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Emotion Recognition Factor Score During Treatment. | 4-week; 8-week | |||
| OTHER_PRE_SPECIFIED | Change From Baseline in Parent Rated Social Responsiveness Scale, Second Edition (SRS-2) Interpersonal Relatedness Factor Score During Treatment. | 4-week; 8-week |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03204786/outcomes?page=2